- Home
- GHRS vs WLKP Comparison
GHRS vs WLKP Comparison
Compare GHRS & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- WLKP
- Stock Information
- Founded
- GHRS 2018
- WLKP 2014
- Country
- GHRS Ireland
- WLKP United States
- Employees
- GHRS N/A
- WLKP N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- WLKP Major Chemicals
- Sector
- GHRS Health Care
- WLKP Industrials
- Exchange
- GHRS Nasdaq
- WLKP Nasdaq
- Market Cap
- GHRS 849.8M
- WLKP 833.7M
- IPO Year
- GHRS 2021
- WLKP 2014
- Fundamental
- Price
- GHRS $12.31
- WLKP $21.94
- Analyst Decision
- GHRS Strong Buy
- WLKP
- Analyst Count
- GHRS 8
- WLKP 0
- Target Price
- GHRS $30.63
- WLKP N/A
- AVG Volume (30 Days)
- GHRS 187.6K
- WLKP 34.4K
- Earning Date
- GHRS 05-08-2025
- WLKP 08-05-2025
- Dividend Yield
- GHRS N/A
- WLKP 8.60%
- EPS Growth
- GHRS N/A
- WLKP N/A
- EPS
- GHRS N/A
- WLKP 1.49
- Revenue
- GHRS N/A
- WLKP $1,088,852,000.00
- Revenue This Year
- GHRS N/A
- WLKP $8.90
- Revenue Next Year
- GHRS N/A
- WLKP $6.87
- P/E Ratio
- GHRS N/A
- WLKP $14.71
- Revenue Growth
- GHRS N/A
- WLKP N/A
- 52 Week Low
- GHRS $6.00
- WLKP $21.19
- 52 Week High
- GHRS $20.50
- WLKP $25.04
- Technical
- Relative Strength Index (RSI)
- GHRS 52.37
- WLKP 34.41
- Support Level
- GHRS $12.43
- WLKP $21.90
- Resistance Level
- GHRS $13.15
- WLKP $22.36
- Average True Range (ATR)
- GHRS 0.99
- WLKP 0.26
- MACD
- GHRS -0.14
- WLKP 0.01
- Stochastic Oscillator
- GHRS 41.03
- WLKP 6.36
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.